Natera Inc (NTRA)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $46.27B
Last updated: Nov 17, 2026 at 11:06 AM ET
Natera Inc (NTRA) Earnings: Report Dates and Results
Natera (NTRA) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Natera reported EPS of -$0.39, below the -$0.17 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NTRA has an expected report date of Feb 24, 2027.
NTRA Earnings Call
The latest NTRA earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, NTRA beat 21, missed 17 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $793.98M, up 34.1% from $592.18M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.39 | -$0.17 | -$0.61 - $0.13 | -129.41% | Miss | N/A | 15 | 2 up, 4 down | Nov 5, 2026 | $793.98M |
| Jun 30, 2026 | -$0.47 | -$0.47 | -$0.76 - -$0.30 | 0.00% | In line | N/A | 13 | 2 up, 0 down | Aug 6, 2026 | $752.75M |
| Mar 31, 2026 | -$0.60 | -$0.55 | -$0.68 - -$0.37 | -9.09% | Miss | N/A | 13 | 1 up, 0 down | May 7, 2026 | $696.64M |
| Dec 31, 2025 | $0.35 | -$0.46 | -$0.93 - -$0.20 | +176.09% | Beat | N/A | 14 | 3 up, 2 down | Feb 26, 2026 | $665.50M |
| Sep 30, 2025 | -$0.64 | -$0.35 | -$0.63 - -$0.17 | -82.86% | Miss | N/A | 14 | 1 up, 0 down | Nov 6, 2025 | $592.18M |
| Jun 30, 2025 | -$0.74 | -$0.60 | -$0.75 - -$0.40 | -23.33% | Miss | N/A | 12 | 2 up, 1 down | Aug 7, 2025 | $546.60M |
| Mar 31, 2025 | -$0.50 | -$0.66 | -$0.79 - -$0.47 | +24.24% | Beat | N/A | 13 | 2 up, 1 down | May 8, 2025 | $501.83M |
| Dec 31, 2024 | -$0.41 | -$0.35 | -$0.62 - -$0.02 | -18.29% | Miss | N/A | 13 | 3 up, 1 down | Feb 27, 2025 | $476.06M |
| Sep 30, 2024 | -$0.26 | -$0.59 | -$0.72 - -$0.48 | +55.93% | Beat | N/A | 18 | 0 up, 0 down | Nov 12, 2024 | $439.76M |
| Jun 30, 2024 | -$0.30 | -$0.68 | -$0.79 - -$0.59 | +55.88% | Beat | N/A | 17 | 2 up, 0 down | Aug 8, 2024 | $413.35M |
| Mar 31, 2024 | -$0.56 | -$0.71 | -$0.78 - -$0.65 | +21.13% | Beat | N/A | 15 | 2 up, 0 down | May 9, 2024 | $367.74M |
| Dec 31, 2023 | -$0.64 | -$0.71 | -$0.87 - -$0.56 | +9.86% | Beat | N/A | 17 | 2 up, 0 down | Feb 28, 2024 | $311.11M |
| Sep 30, 2023 | -$0.95 | -$0.97 | -$1.09 - -$0.83 | +2.06% | Beat | N/A | 14 | 0 up, 1 down | Nov 8, 2023 | $268.31M |
| Jun 30, 2023 | -$0.97 | -$1.10 | -$1.22 - -$0.98 | +11.82% | Beat | N/A | 15 | 1 up, 0 down | Aug 3, 2023 | $261.40M |
| Mar 31, 2023 | -$1.23 | -$1.16 | -$1.28 - -$1.04 | -6.03% | Miss | N/A | 15 | 1 up, 0 down | May 9, 2023 | $241.76M |
| Dec 31, 2022 | -$1.37 | -$1.42 | -$1.58 - -$1.30 | +3.52% | Beat | N/A | 13 | 1 up, 0 down | Feb 28, 2023 | $217.25M |
| Sep 30, 2022 | -$1.25 | -$1.44 | -$1.52 - -$1.33 | +13.19% | Beat | N/A | 13 | 1 up, 0 down | Nov 8, 2022 | $210.64M |
| Jun 30, 2022 | -$1.50 | -$1.50 | -$1.63 - -$1.37 | 0.00% | In line | N/A | 12 | 0 up, 1 down | Aug 4, 2022 | $198.20M |
| Mar 31, 2022 | -$1.45 | -$1.52 | -$1.74 - -$1.37 | +4.61% | Beat | N/A | 12 | 1 up, 0 down | May 5, 2022 | $194.13M |
| Dec 31, 2021 | -$1.48 | -$1.31 | -$1.39 - -$1.12 | -12.98% | Miss | N/A | 10 | N/A | Feb 24, 2022 | $173.03M |
| Sep 30, 2021 | -$1.63 | -$1.33 | -$1.36 - -$1.06 | -22.56% | Miss | N/A | 10 | N/A | Nov 4, 2021 | $158.12M |
| Jun 30, 2021 | -$1.32 | -$1.20 | -$1.40 - -$0.99 | -10.00% | Miss | N/A | 11 | N/A | Aug 5, 2021 | $142.03M |
| Mar 31, 2021 | -$0.74 | -$1.03 | -$1.13 - -$0.78 | +28.16% | Beat | N/A | 9 | N/A | May 6, 2021 | $152.32M |
| Dec 31, 2020 | -$0.92 | -$0.62 | -$0.81 - -$0.48 | -48.39% | Miss | N/A | 10 | N/A | Feb 25, 2021 | $112.38M |
| Sep 30, 2020 | -$0.72 | -$0.70 | -$0.77 - -$0.61 | -2.86% | Miss | N/A | 9 | N/A | Nov 5, 2020 | $98.14M |
| Jun 30, 2020 | -$0.68 | -$0.60 | -$0.73 - -$0.46 | -13.33% | Miss | N/A | 6 | N/A | Aug 5, 2020 | $86.47M |
| Mar 31, 2020 | -$0.45 | -$0.52 | -$0.68 - -$0.50 | +13.46% | Beat | N/A | 6 | N/A | May 6, 2020 | $94.01M |
| Dec 31, 2019 | -$0.44 | -$0.55 | -$0.72 - -$0.38 | +20.00% | Beat | N/A | 6 | N/A | Feb 26, 2020 | $83.24M |
| Sep 30, 2019 | -$0.53 | -$0.55 | -$0.62 - -$0.47 | +3.64% | Beat | N/A | 6 | N/A | Nov 6, 2019 | $77.91M |
| Jun 30, 2019 | -$0.48 | -$0.56 | -$0.62 - -$0.52 | +14.29% | Beat | N/A | 6 | N/A | Aug 7, 2019 | $74.36M |
| Mar 31, 2019 | -$0.54 | -$0.60 | -$0.67 - -$0.52 | +10.00% | Beat | N/A | 6 | N/A | May 9, 2019 | $66.82M |
| Dec 31, 2018 | -$0.51 | -$0.52 | -$0.58 - -$0.42 | +1.92% | Beat | N/A | 6 | N/A | Mar 12, 2019 | $66.97M |
| Sep 30, 2018 | -$0.49 | -$0.48 | -$0.55 - -$0.38 | -2.08% | Miss | N/A | 7 | N/A | Nov 8, 2018 | $65.28M |
| Jun 30, 2018 | -$0.55 | -$0.57 | -$0.60 - -$0.41 | +3.51% | Beat | N/A | 8 | N/A | Aug 8, 2018 | $63.07M |
| Mar 31, 2018 | -$0.61 | -$0.62 | -$0.84 - -$0.45 | +1.61% | Beat | N/A | 8 | N/A | May 8, 2018 | $62.34M |
| Dec 31, 2017 | -$0.85 | -$0.47 | -$0.57 - -$0.37 | -80.85% | Miss | N/A | 7 | N/A | Mar 13, 2018 | $52.05M |
| Sep 30, 2017 | -$0.51 | -$0.48 | -$0.55 - -$0.42 | -6.25% | Miss | N/A | 6 | N/A | Nov 8, 2017 | $55.91M |
| Jun 30, 2017 | -$0.52 | -$0.54 | -$0.60 - -$0.46 | +3.70% | Beat | N/A | 6 | N/A | Aug 8, 2017 | $52.28M |
| Mar 31, 2017 | -$0.70 | -$0.67 | N/A | -4.48% | Miss | N/A | N/A | N/A | May 9, 2017 | $49.38M |
| Dec 31, 2016 | -$0.73 | -$0.61 | N/A | -19.67% | Miss | N/A | N/A | N/A | Mar 7, 2017 | $44.74M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.53, after -$1.53 the year before. It was -$1.86 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.53 | N/A |
| Dec 31, 2024 | -$1.53 | N/A |
| Dec 31, 2023 | -$3.79 | N/A |
| Dec 31, 2022 | -$5.57 | N/A |
| Dec 31, 2021 | -$5.17 | N/A |
| Dec 31, 2020 | -$2.77 | N/A |
| Dec 31, 2019 | -$1.99 | N/A |
| Dec 31, 2018 | -$2.16 | N/A |
| Dec 31, 2017 | -$2.58 | N/A |
| Dec 31, 2016 | -$1.86 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,700 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,688 | 11 | |
| 2026Q2 | Jun 30, 2026 | 8,867 | 12 | |
| 2026Q1 | Mar 31, 2026 | 8,861 | 15 | |
| 2025Q4 | Dec 31, 2025 | 7,360 | 13 | |
| 2025Q3 | Sep 30, 2025 | 6,492 | 13 | |
| 2025Q2 | Jun 30, 2025 | 8,650 | 10 | |
| 2025Q1 | Mar 31, 2025 | 8,444 | 11 | |
| 2024Q4 | Dec 31, 2024 | 11,157 | 14 |
2026Q3 Earnings Call
Opening remarks
Michael Brophy CFO Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss the results of our third quarter of 2026. On the line, I am joined by Steven Leonard Chapman, Solomon Moshkevich, and Alexey Aleshin. Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of the call will also be posted to our investor relations website as soon as it is available. In the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our operational and financial outlook and projections, our assumptions for that outlook, market size, partnerships, clinical studies and expected results, opportunities and strategies, and expectations for various current and future products, including product capabilities, expected release dates, reimbursement coverage, and related effects on our financial and operating results. We caution you that such statements reflect our best judgment based on factors currently known to us and that actual events or results could differ materially. Please refer to the documents we file from time to time with the SEC, including our most recent Form 10-K or 10-Q and the Form 8-K filed today with today's press release. Those documents identify important risks and other factors that may cause our actual results to differ materially from those contained in or suggested by the forward-looking statements. Forward-looking statements made during the call are being made as of today, November 5, 2026. If this call is replayed or reviewed after today, the information presented during the call may not be current or accurate. Natera disclaims any obligation to update or revise any forward-looking statements. We will provide guidance on today's call, but we will not provide any further guidance or updates on our performance during the quarter unless we do so in a public forum. We will quote a number of numeric or growth changes as we discuss our financial performance. Unless otherwise noted, each such reference represents a year-over-year comparison. And now I would like to turn the call over to Steven. Steven?
Steven Leonard Chapman CEO Hi, everyone, and thanks for joining us this afternoon. As you may have seen by now in the press release, I am stepping down from the CEO role, as now is an excellent time to transition to new leadership for Natera. We have had an incredible run during my time here since joining in 2010. My last almost eight years as CEO have been particularly meaningful to me, and I am extremely proud of all we have accomplished in that time.
Frequently Asked Questions About NTRA
When is Natera's next earnings date?
Natera's next earnings report is expected for Feb 24, 2027.
Did NTRA beat earnings estimates last quarter?
No. Natera reported EPS of -$0.39 for the quarter ended Sep 30, 2026, below the -$0.17 estimate by 129.41%.
What EPS do analysts expect from NTRA next quarter?
The consensus EPS estimate for Natera for the quarter ending Dec 31, 2026 is -$0.13 from 23 analysts, with estimates from -$0.39 to $0.05.
How often does NTRA beat earnings estimates?
Natera beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -7.83%.
NTRA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts